Amanote Research
Register
Sign In
BCL2-associated X Protein (BAX); BCL2-antagonist/killer 1 (BAK1)
Science-Business eXchange
doi 10.1038/scibx.2010.1154
Full Text
Open PDF
Abstract
Available in
full text
Date
September 1, 2010
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737
Journal of Clinical Investigation
Medicine
Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates P38 Signaling
American Journal of Pathology
Forensic Medicine
Pathology
Targeting BCL2 With Venetoclax Is a Promising Therapeutic Strategy for "Double-Protein-Expression" Lymphoma With MYC and BCL2 Rearrangements
Haematologica
Hematology
BCL2/adenovirus E1B 19kDa Interacting Protein 3-Like (BNIP3L; NIX)
Science-Business eXchange
Effect of Ascorbic Acid on Signaling Pathways of Bcl2 and Bax Genes in AGS Cell Line
journal of ilam university of medical sciences
Post-Transcriptional and Post-Translational Regulation of Bcl2: Figure 1
Biochemical Society Transactions
Biochemistry
Effect of Magnevist Conjugated Dendrimer on Bax/Bcl2 Gene Expression Levels in McF-7 Cancer Cells
Journal of Experimental Biology and Agricultural Sciences
BCL2 (B-Cell Leukemia/Lymphoma 2)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
BCL2/MDM2 Inhibitor Combo Effective in AML
Cancer Discovery
Oncology
